Eric Rovner to Benzhydryl Compounds
This is a "connection" page, showing publications Eric Rovner has written about Benzhydryl Compounds.
Connection Strength
1.510
-
Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms. J Urol. 2008 Sep; 180(3):1034-41.
Score: 0.301
-
Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology. 2008 Sep; 72(3):488-93.
Score: 0.301
-
Tolterodine for the treatment of overactive bladder: a review. Expert Opin Pharmacother. 2005 Apr; 6(4):653-66.
Score: 0.239
-
Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int. 2010 May; 105(9):1268-75.
Score: 0.082
-
Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009 Sep; 182(3):1055-61.
Score: 0.081
-
Fesoterodine dose response in subjects with overactive bladder syndrome. Urology. 2008 May; 71(5):839-43.
Score: 0.073
-
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006 Nov 15; 296(19):2319-28.
Score: 0.067
-
Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology. 2006 Aug; 68(2):328-32.
Score: 0.066
-
Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence. BJU Int. 2006 May; 97(5):1003-6.
Score: 0.064
-
Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006 Apr; 67(4):731-6; discussion 736.
Score: 0.064
-
Trospium chloride in the management of overactive bladder. Drugs. 2004; 64(21):2433-46.
Score: 0.055
-
Update on overactive bladder: pharmacologic approaches on the horizon. Curr Urol Rep. 2003 Oct; 4(5):385-90.
Score: 0.054
-
Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. Eur Urol. 2002 Jan; 41(1):6-14.
Score: 0.048
-
The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW. Value Health. 2005 Nov-Dec; 8 Suppl 1:S25-34.
Score: 0.016